> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on Biosimilar User Fee Program Assessment
- URL: https://www.fdaweb.com/meeting-on-biosimilar-user-fee-program-assessment/
- Published: 2022-02-23T12:00:00.000Z
- Updated: 2026-09-14T17:33:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151218

*Federal Register* notice: FDA is announcing a 3/22 virtual public meeting entitled “Final Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act (BsUFA),” and an opportunity for public comment. The topics to be discussed are the final assessment and public stakeholder views about the program. To view the notice, click [here](https://public-inspection.federalregister.gov/2022-03926.pdf?ref=fdaweb.com).